Microcap Ledger China Pharma Holdings, Inc. $CPHI
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- NYSE American
- Sector
- Pharmaceutical Preparations
- Headquarters
- Hainan Province, China
- Fiscal year end
- December 31
- Shares outstanding
- 43,022,002 [10-Q 2026-08-14]
What the company doesAI summary of filing
China Pharma Holdings Inc. is a Nevada holding company that develops, manufactures, and markets pharmaceutical products in the People's Republic of China through its wholly owned subsidiary Helpson. The company produces 19 pharmaceutical products in various forms (tablets, capsules, injectables) targeting high-incidence and high-mortality diseases, including cardiovascular, central nervous system, infectious, and digestive conditions, along with comprehensive healthcare and protective products. All products are approved by China's National Medical Products Administration and sold primarily on a prescription basis to hospitals and pharmacies through a provincial and municipal distribution network. The company is revenue-generating, with total revenues of approximately $4.1 million in 2025 across its three pharmaceutical product categories. [10-K 2026-04-01]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $1.93M | −$2.60M | −$88.1K | $304.9K | [10-Q 2026-08-14] |
| FY ended Dec 2025 | $4.14M | −$3.19M | $148.3K | $345.1K | [10-K 2026-04-01] |
| FY ended Dec 2024 | $4.53M | −$4.74M | −$406.1K | $626.9K | [10-K 2026-04-01] |
- Quarterly cash burn
- −$44.1K
- Cash runway Estimate
- ~20.8 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-12 | 19,253,363 | [10-Q 2024-11-13] |
| 2025-03-24 | 32,619,109 | [10-K 2025-03-31] |
| 2025-05-14 | 3,262,002 | [10-Q 2025-05-14] |
| 2025-08-07 | 3,262,002 | [10-Q 2025-08-14] |
| 2025-11-10 | 5,022,002 | [10-Q 2025-11-12] |
| 2026-03-25 | 40,522,002 | [10-K 2026-04-01] |
| 2026-05-11 | 40,522,002 | [10-Q 2026-05-15] |
| 2026-08-11 | 43,022,002 | [10-Q 2026-08-14] |
- Shelf registration
- S-3 filed 2024-01-12; declared effective 2024-02-14 [S-3 2024-01-12]
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-14 | 10-Q | Quarterly report |
| 2026-07-23 | 424B5 | Prospectus or prospectus supplement |
| 2026-07-22 | 8-K | Material agreement entered; Other events |
| 2026-05-15 | 10-Q | Quarterly report |
| 2026-04-01 | 10-K | Annual report |
| 2026-04-01 | NT 10-K | Notice of late annual report |
| 2026-03-03 | 8-K | Material agreement entered; Unregistered sale of equity |
| 2026-02-10 | 8-K | Material agreement entered; Unregistered sale of equity |
| 2026-01-06 | 8-K | Shareholder vote results |
| 2025-12-23 | 8-K | Material agreement entered; Unregistered sale of equity |
| 2025-12-10 | 8-K | Material agreement entered; Unregistered sale of equity |
| 2025-11-14 | DEF 14A | Proxy statement |
Alerts for $CPHI
Email me when China Pharma Holdings, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.